Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 1, 2006
Reporting Period: The filing announces financial results for the three and nine months ended September 30, 2006.
Key Financial Metrics
The provided text serves as a cover document referencing a press release (Exhibit 99.1) for detailed data. The filing text itself does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached press release for specific financial figures.
Material Changes
The filing text does not contain specific data regarding material changes versus prior comparable periods. It only confirms the issuance of results for the periods ended September 30, 2006.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release on November 1, 2006, announcing the aforementioned financial results.
Legal Disclaimer: The information in this Current Report and the attached Exhibit shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor subject to the liabilities of that section, except as expressly set forth by specific reference in other filings.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the three and nine months ended September 30, 2006.
- Verify year-over-year growth rates and margin trends in the attached press release.
- Check for any forward-looking statements or guidance included in the press release that are not present in this 8-K summary.
- Confirm the status of the Company's liquidity and debt obligations as detailed in the full financial disclosure.